Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-31 @ 2:24 AM
Study NCT ID:
NCT07399067
Status:
RECRUITING
Last Update Posted:
2026-02-13
First Post:
2026-01-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Proof-of-Concept Study of IBI3002 in Patients With Moderate to Severe Atopic Dermatitis
Sponsor:
Innovent Biologics (Suzhou) Co. Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-02-06
Start Date Type:
ACTUAL
Primary Completion Date:
2027-03-23
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-05-27
Completion Date Type:
ESTIMATED
First Submit Date:
2026-01-15
First Submit QC Date:
None
Study First Post Date:
2026-02-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-02-11
Last Update Post Date:
2026-02-13
Last Update Post Date Type:
ACTUAL